Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis
The Journal of Physiology · 2023-07 · 601 (14) · 2801-2826
DOI: 10.1113/jp284289 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Physiology, online erschienen am 08.06.2023. Verfasst von Umut Rende und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Kidney, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Health, NSW Health PhD Partnership Program Scholarship.
Abstract (Originalsprache)
Renal fibrosis is the final common pathophysiological pathway in chronic kidney disease (CKD) regardless of the underlying cause of kidney injury. Tubulointerstitial fibrosis (TIF) is considered to be the key pathological predictor of CKD progression. Currently, the gold‐standard tool to identify TIF is kidney biopsy, an invasive method that carries risks. Non‐invasive diagnostics rely on an estimation of glomerular filtration rate and albuminuria to assess kidney function, but these fail to diagnose early CKD accurately or to predict progressive decline in kidney function. In this review, we summarize the current and emerging molecular biomarkers that have been studied in various clinical settings and in animal models of kidney disease and that are correlated with the degree of TIF. We examine the potential of these biomarkers to diagnose TIF non‐invasively and to predict disease progression. We also examine the potential of new technologies and non‐invasive diagnostic approaches in assessing TIF. Limitations of current and potential biomarkers are discussed and knowledge gaps identified. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, The University of New South Wales, Sydney, NSW, Australia.
- Macquarie Medical School, Faculty of Medicine, Health & Human Sciences, Macquarie University, NSW, Australia.
- Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia.
ORCID-Profile: Umut Rende, Sonia Saad
Förderung
- NSW Health
- NSW Health PhD Partnership Program Scholarship
Zitieren
APA
Rende, U., Guller, A., Goldys, E. M., Pollock, C., & Saad, S. (2023). Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology, 601(14), 2801-2826. https://doi.org/10.1113/jp284289
Vancouver
Rende U, Guller A, Goldys EM, Pollock C, Saad S. Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis. The Journal of Physiology. 2023;601(14):2801-2826. doi:10.1113/jp284289
BibTeX
@article{Rende2023,
author = {Rende, Umut and Guller, Anna and Goldys, Ewa M and Pollock, Carol and Saad, Sonia},
title = {Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis},
journal = {The Journal of Physiology},
year = {2023},
volume = {601},
number = {14},
pages = {2801--2826},
doi = {10.1113/jp284289}
}
EUVIMED